Pfizer Inc. (LON:0Q1N)

London flag London · Delayed Price · Currency is GBP · Price in USD
26.19
+0.02 (0.08%)
At close: Jan 30, 2026
-2.46%
Market Cap109.58B -9.8%
Revenue (ttm)46.82B +3.9%
Net Income7.33B +131.2%
EPS1.29 +131.9%
Shares Outn/a
PE Ratio14.95
Forward PE9.00
Dividend1.29 (4.91%)
Ex-Dividend DateJan 23, 2026
Volume98,504
Average Volume117,266
Open25.99
Previous Close26.17
Day's Range25.90 - 26.22
52-Week Range20.77 - 27.88
Beta0.43
RSI58.86
Earnings DateFeb 3, 2026

About Pfizer

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular and migraine under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral pr... [Read more]

Industry Pharmaceutical Preparations
Founded 1849
Employees 81,000
Stock Exchange London Stock Exchange
Ticker Symbol 0Q1N
Full Company Profile

Financial Performance

In 2024, Pfizer's revenue was $63.63 billion, an increase of 6.84% compared to the previous year's $59.55 billion. Earnings were $8.03 billion, an increase of 279.00%.

Financial numbers in USD Financial Statements